Home›Companies›Biotech & Pharma›Biolog

Biolog, Inc.

Updated Oct 27, 2026·Latest SEC filing Feb 19, 2025·Suggest an edit

About Biolog

Biolog is a private company based in Hayward, California, incorporated in 2022 in Delaware. It has reported $33,622,991 raised in two offerings on Form D since July 2022. Its chief executive is Robert Wicke.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Feb 10, 2025Feb 19, 2025$16,122,991of $17.1M target22$732KEquityRule 506(b)Form D ↗
Apr 28, 2022Jul 28, 2022amended Feb 6, 2023$17,500,000fully sold20$875KEquityRule 506(b)Form D/A ↗1 earlier filing
Total, two offerings$33,622,991

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Biolog's Form D filed Feb 19, 2025.

TH
Tim Harkness
Director
Also a director at LabVoice.
WS
RW
Robert Wicke
Chief Executive Officer and director
CS

Earlier filings also listed Joseph Keegan (director, last listed Feb 2023), Jason Novi (cfo, last listed Feb 2023) and David Weber (director, last listed Feb 2023).

Sources

  1. SECBiolog, Inc. /DE/ Form D, filed Jul 28, 2022
  2. SECBiolog, Inc. /DE/ filing history